Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic H... (tinuation this patient hadundetectable H...)

Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C

Date:4/25/2008

tinuation, this patient had undetectable HCV RNA. R7128 was generally safe and well-tolerated when administered for 4 weeks in combination with Pegasus plus Copegus in patients with HCV genotype 1.

Please see http://www.clinicaltrials.gov or e-mail clinicaltrials@pharmasset.com for more information.

Conference Call

Pharmasset will host a conference call at 1:00 PM ET (US) and 7:00 PM CEST (Milan) on Friday, April 25, 2008 to discuss the R7128 500mg and 1500mg combination study results, as well as the addition of two R7128 cohorts to the on-going Phase 1 protocol.

Dial-in Information:

US/Canada Toll-Free callers: +1 (877) 545-1490

US/Canada Toll or International Toll callers: +1 (719) 325-4884

Live audio of the conference call will be simultaneously broadcast over the internet via a webcast. To access the live webcast, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's corporate website at http://investor.pharmasset.com/events.cfm .

Please connect to the company's website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary to listen to the webcast. The archived replay of the webcast will be available on the Pharmasset website for two weeks following the conference call.

About R7128

R7128 is being developed for the treatment of chronic HCV infection. R7128 is a prodrug of PSI-6130, a cytidine nucleoside analog inhibitor of HCV RNA polymerase. A prodrug is a chemically modified form of a molecule designed to enhance the absorption, distribution and metabolic properties of that molecule. Results from an oral single ascending dose study of PSI-6130 in 24 healthy male volunteers showed that PSI-6130 was generally well tolerated with no
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
2. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
3. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
6. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
7. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
8. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
9. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
10. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
11. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR

Post Your Comments:

(Date:12/15/2009)... Mass., Dec. 15 /PRNewswire-FirstCall/ ... today announced that SDMS Vision Publisher(TM) (v.7.1 SR4), ... Scientific Data Management System (SDMS), a secure electronic ... scientific data to a centralized database and is ... has been certified compliant with the SAFE-BioPharma digital ...

(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The Future ... to 2015, Competitive Benchmarking, Product Pipeline ... http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, Summary ... latest research "The Future of HIV ...

(Date:12/15/2009)... DIEGO, Dec. 15 Safe Life ... developing novel technologies that prevent the spread of ... ramping production of its comfortable, breathable, A400 Series ... address the global shortage of N95 respirators during ... capacity in response to a rapid rise in ...

[0] Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard [0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage

... Reduce Threat of ... NEW YORK, Aug. 1 Congressionally appropriated funds to,determine ... to the Copper Development Association, announced CDA President,Andrew G. Kireta ... copper metals to kill deadly,pathogens on touch surfaces in hospital ...

... Completed; Clinical Update Provided for NicVAX Phase 2b Proof of Concept ... ... Fla., Aug. 1 Nabi,Biopharmaceuticals (Nasdaq: NABI ) today announced its ... $5.3 million, or $0.09 per share, for the quarter ended June,30, 2007, ...

Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results

(Date:12/15/2009)... promised but not delivered ,, WASHINGTON, Dec. ... Congress to ensure that healthcare reform does not ... of insurance companies in 37 states. ,, Prostate ... of the population and individuals who are identifiable ... men who have a family history of prostate ...

(Date:12/15/2009)... WASHINGTON, Dec. 15 ... Republican Women Members of Congress that, "it doesn,t matter ... House bills - without a public option - give ... The bills also fund a new social agenda by ... inner city groups, newly arriving immigrants, and local politicians." ...

(Date:12/15/2009)... is known to reduce depression and fatigue in people ... this effect stems from an individual,s sense of mastery ... to achieve certain physical goals. , The study ... "We base our arguments on fatigue being a symptom ... and community health at the University of Illinois and ...

(Date:12/15/2009)... in teens, study suggests , , TUESDAY, Dec. 15 (HealthDay ... the risk of obstructive sleep apnea, but the same ... Australian researchers have found. , In sleep tests conducted ... were referred for evaluation of snoring and possible obstructive ... 12 and older the risk of obstructive sleep apnea ...

(Date:12/15/2009)... cardiovascular event, suicide goes up within a week ... 15 (HealthDay News) -- Emotional stress can put ... for cardiovascular events and suicide, a new study ... Swedish men diagnosed with prostate cancer between 1961 ... experienced a cardiovascular event within a year of ...

Breaking Medicine News(10 mins):Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2 Health News:Mastery of physical goals lessens disease-related depression and fatigue 2 Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2

[1] Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform [1] Hear the Truth about the Health Bills [0] Mastery of physical goals lessens disease-related depression and fatigue [0] Puberty May Trigger Sleep Apnea in Overweight Kids [0] Stress From Prostate Cancer Diagnosis May Be Fatal

... Black Americans have a higher occurrence of colon polyps, according ... the incidence of colon cancer among black men has increased ... years. , The article will be published in the Sept. ... American Medical Association ). , The new study, led by ...

... nation,s,leading association for professionally managed assisted living companies,today ... of life choices,made by aging Americans., Richard ... Living Federation,of America (ALFA), said the assisted living ... in testimony submitted to the Senate Special,Committee on ...

... by union and nonunion caregivers blends online,phone-bank technology ... WASHINGTON, Sept. 24 With women voters,poised to ... a unique,project of SEIU Healthcare will reach at ... workforce -- through worker-to-worker,communication on the candidates, views ...

... analyzed in 83 cases of colorectal carcinoma and ... (PCR). PCR products were eletrophoresed on an ABI ... software were used for loss of heterozygosity (LOH) ... relationship was observed between LOH frequencies on D4S3018 ...

... 24 Americans United for Life,(AUL) has filed ... Services,(HHS) affirming the need for a proposed regulation ... providers nationwide., Dr. Charmaine Yoest, President and ... providers is critical to the continuing viability and,safety ...

... nation,s,leading supplier of replacement medical repair parts for hospital,equipment, ... 2008 INC 500,for healthcare. This marks the third straight ... one of the fastest growing companies in,America., "We ... as INC,magazine recognize our tremendous growth," said President & ...

Other Medicine News:Health News:Black Americans are at higher risk for colon polyps 2 Health News:ALFA Honors End of Life Choices 2 Health News:Nurses, Healthcare Workers Launch Massive Drive to Inform 1 Million Caregivers in Key States on Obama and McCain Healthcare Plans 2 Health News:LOH analysis on 4q in sporadic colorectal carcinoma 2 Health News:Conscience Protections Essential to Healthcare System, Americans United for Life Argues in Comments Filed with HHS 2

Black Americans are at higher risk for colon polyps ALFA Honors End of Life Choices Nurses, Healthcare Workers Launch Massive Drive to Inform 1 Million Caregivers in Key States on Obama and McCain Healthcare Plans LOH analysis on 4q in sporadic colorectal carcinoma Conscience Protections Essential to Healthcare System, Americans United for Life Argues in Comments Filed with HHS PartsSource Named 81st Fastest Growing Company on INC 500 for Healthcare

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

Medicine Products:

Drugs of Abuse Confirmation/Quantitation-Opiates-Serum or Plasma Drugs of Abuse Confirmation/Quantitation-Methadone & Metabolite-Serum or Plasma Drugs of Abuse Confirmation/Quantitation-Fentanyl and Metabolite-Urine Drugs of Abuse Confirmation/Quantitation-Codeine & Metabolite-Urine

Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic H...(tinuation this patient hadundetectable H...),Health